Cargando…
Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644397/ http://dx.doi.org/10.1007/s40278-020-84853-1 |
Ejemplares similares
-
Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021) -
Caspofungin/ceftriaxone/hydroxychloroquine: Brugada syndrome and off-label use: case report
Publicado: (2021) -
Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022) -
Ceftriaxone/levofloxacin/lopinavir/ritonavir: Thrombocytopenia following off-label use: case report
Publicado: (2021) -
Anti-bacterial/heparin/hydroxychloroquine: Off label use and resistance: case report.
Publicado: (2020)